Chronic Idiopathic Urticaria (Investigational Adjunct)

Patient Summary

Is this FDA-cleared for this use?

Not FDA-cleared for chronic idiopathic / spontaneous urticaria. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, June 2004). Use here is Tier C investigational.

What evidence exists?

Tier C (investigational). No controlled trials. Evidence-based first-line management is second-generation H1 antihistamines at standard doses, uptitrated up to fourfold if needed, addition of H2 antihistamine or leukotriene receptor antagonist, omalizumab (FDA-approved for chronic spontaneous urticaria refractory to antihistamines), and for refractory disease cyclosporine or other immunomodulators under specialist supervision.

Main risks

• Bleeding from each bite site for 6 to 10 hours after the leech detaches
• Iron-deficiency anemia from cumulative blood loss across multiple sessions
• Aeromonas hydrophila wound infection from leech gut bacteria (uncommon outside reconstructive surgery, but possible)
• Allergic reaction to leech saliva (rare; ranges from local itching to anaphylaxis)
• Permanent Y-shaped bite-mark scars or hyperpigmentation at attachment sites
• Local pain, bruising, swelling, or itching for 1 to 3 days after each session
• Allergic reactions to leech proteins may be misinterpreted as urticaria flare
• Risk of anaphylaxis (already concerning in this population)
• Triggering urticarial flare from cutaneous trauma

Who should not consider this

• Patients who have not had fourfold-uptitrated H1 antihistamine for 4+ weeks
• Patients eligible for omalizumab who have not been offered it
• Patients with known anaphylaxis to leeches or other arthropod proteins
• Patients with autoimmune urticaria with positive autologous serum skin test (these may need immunomodulators)
• Anyone on blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran, heparin, or daily aspirin used for medical reasons
• People with hemophilia or any other inherited bleeding disorder
• Patients with severe anemia (hemoglobin under 10 g/dL)

What to ask your clinician

• Have I been on fourfold-uptitrated H1 antihistamine?
• Has omalizumab — FDA-approved for chronic spontaneous urticaria — been considered?
• Have triggers and physical urticaria types been ruled out?
• What is the published evidence base for leeches in CIU?
• What is the plan if my urticaria flares severely from bites?
• What is the anaphylaxis-prevention plan?

When to seek urgent care

• Bleeding from a bite site that soaks through more than one dressing per hour
• Bleeding that continues more than 24 hours after the leech detached
• Spreading redness, warmth, swelling, pus, or red streaks around any bite site
• Fever over 38.0 C / 100.4 F, chills, or feeling suddenly unwell after a session
• Hives, facial or tongue swelling, throat tightness, or any difficulty breathing
• Sudden weakness, dizziness, fast heart rate, or fainting (possible severe blood loss)
• Severe widespread hives with throat swelling, breathing difficulty, lightheadedness, or vomiting (anaphylaxis — emergency)
• Sudden severe abdominal pain or syncope